Dose Escalating Study of CCI15106 Inhalation Capsules in Healthy Subjects and Moderate Chronic Obstructive Pulmonary Disease (COPD) Patients
Clinical trial NCT03243760 · TERMINATED
Trial details
- NCT number
- NCT03243760
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-10
- Primary completion
- 2016-07-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.